<DOC>
	<DOCNO>NCT01915082</DOCNO>
	<brief_summary>This study investigate possible beneficial effect peri-operative treatment ( i.e . pre-transplant initiation prompt post-transplant continuation ) azithromycin lung transplantation . Our hypothesis therapy improve early allograft function outcome follow human lung transplantation .</brief_summary>
	<brief_title>Peri-operative Azithromycin Improve Early Allograft Function Outcome After Lung Transplantation</brief_title>
	<detailed_description>After lung transplant recipient put wait list subsequent lung transplantation , informed consent seek current study . If sign informed obtain , patient enrol upon admission transplantation moment he/she randomise placebo azithromycin accord blind randomisation-list . In accordance his/her attribute study-number , include patient assign pre-numbered bottle contain study-drug , pre-filled blind content deliver advance ward University Leuven Hospital Pharmacy . From bottle , first load dose placebo ( 25 mL po syrup ) azithromycin ( 25 mL po syrup = 1000 mg ) give nurse preparation subsequent lung transplantation ( Day 0 ) . After lung transplantation , 'add ' treatment placebo ( 6.25 mL ) azithromycin ( 6.25 mL = 250 mg ) syrup give via ( naso ) gastric tube per o every day ( day 1,3,5,7,9,11,13,15,17,19,21,23,25,27,29 31 ) nurse take care patient early post-transplant period . In case serious suspect drug-interactions ( however unlikely ) adverse attributable study drug , study promptly stop patient . Serious adverse event monitor treat lung transplant physician ( blind study-drug ) define allergic reaction include skin reaction ( rash , urticaria Stevens-Johnson syndrome ) , angioneurotic edema anaphylaxis , cardiac arrhythmia ( ventricular tachycardia torsades de pointes ) , neurologic disorder ( convulsion ) . Routine immunosuppressive , prophylactic necessary antimicrobial treatment accord standardize protocol give patient , independent study drug . After transplantation , routine follow-up ( e.g . biochemical microbiological blood analysis , chest radiography , pulmonary function test bronchoscopic evaluation broncho-alveolar lavage and/or trans- endobronchial biopsy perform currently routinely perform part standard , prospective follow-up lung transplantation .</detailed_description>
	<mesh_term>Azithromycin</mesh_term>
	<criteria>Signed informed consent Adult ( age least 18 year old moment transplantation ) Single lung transplantation , sequential single ( double ) lung transplantation heartlung transplantation Known previous allergy azithromycin ( include skin reaction rash , urticaria Stevens Johnson syndrome , angioneurotic oedema anaphylaxis ) Retransplantation multiorgan ( heartlung ) transplantation Inclusion Transmedics® Organ Care System ( OCS™ LUNG ) study ( OCSLUN032010 ) ( S53795 ) .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
	<keyword>Lung Function</keyword>
	<keyword>Allograft Outcome</keyword>
</DOC>